Sector Watch: Healthcare - Sep 21 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $118.55 -0.74 -0.62% | XBI: $95.54 -1.55 -1.59% | Updated Sep 21, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| VRML Vermillion $53.4M |
0.71+0.12 165.6 K |
20% | ||
| HRT Arrhythmia Research Technology $267.4M |
0.46+0.07 4.3 M 7.2x |
18% | ||
| SSKN52WH Strata Skin Sciences $103.0M |
3.75+0.31 549.9 K |
9% | ||
| MRNS Marinus Pharmaceuticals $355.8M |
8.78+0.72 2.0 M 4.5x |
9% | ||
| NVAX Novavax $612.2M |
1.60+0.13 16.1 M 4.3x |
9% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| NTLA Intellia Therapeutics $1.2B |
26.78-4.73 1.6 M 3.3x |
-15% | ||
| CRBP Corbus Pharmaceuticals Holdings $397.6M |
6.95-1.00 8.6 M 8.3x |
-13% | ||
| OCX OncoCyte $93.5M |
2.30-0.30 60.2 K |
-12% | ||
| ABEO Abeona Therapeutics $605.3M |
12.63-1.37 1.4 M 3.1x |
-10% | ||
| FWP Forward Pharma A/S $112.3M |
2.38-0.24 31.6 K 1.5x |
-9% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
BioTime Warrants to Expire on October 1, 2018 | Business Wire [businesswire.com]Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) [globenewswire.com]
Corbus Pharmaceuticals Expands Target Indications by Adding More Than 600 Compounds Focused on the Endocannabinoid System from Jenrin Discovery; Includes CRB-4001 with Planned NIH-Supported Phase 2 Study [globenewswire.com]
Forward Pharma Reports Financial and Operational Results from the First Six Months of 2018 [globenewswire.com]
Corbus Pharmaceuticals Receives Orphan Designation for Lenabasum for the Treatment of Dermatomyositis in the European Union [globenewswire.com]
BioTime Updates Timeline for Distribution of AgeX Shares to BioTime Shareholders | Business Wire [businesswire.com]
STRATA Skin Sciences to Participate in Panel Discussion at The MedTech Conference Nasdaq:SSKN [globenewswire.com]
BioTime Updates Timeline for Distribution of AgeX Shares to BioTime Shareholders | Business & Finance | manchestertimes.com [businesswire.com]
Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2018 ACR Annual Meeting [globenewswire.com]
Abeona Therapeutics Announces Authorization to Commence Phase 1/2 Gene Therapy Clinical Study for Patients with MPS IIIB in Spain [globenewswire.com]
In-Vitro Diagnostics World Market 2018-2028 - Visiongain Report [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
